BORREGAARD BIOPLANT ApS: Financial statements 2012
CVR: 21500445
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,093,488 and a net result of DKK 651,616. Equity in the 2012 report amounted to DKK 2,910,202. The solvency ratio was 73.7%.
- Gross Profit
- DKK 1,093,488
- Profit/Loss
- DKK 651,616
- Equity
- DKK 2,910,202
- Total Assets
- DKK 3,947,317
Official annual report
Keep an eye on BORREGAARD BIOPLANT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 23, 2012, Anders Dyekjær Madsen has joined the board of directors of BORREGAARD BIOPLANT ApS.
As of May 23, 2012, Torben Huus-Bruun has joined the board of directors of BORREGAARD BIOPLANT ApS.
As of May 23, 2012, Dorthe Bendix Christensen has left the board of directors of BORREGAARD BIOPLANT ApS.
As of January 31, 2012, Dorthe Bendix Christensen has joined the board of directors of BORREGAARD BIOPLANT ApS.
As of January 31, 2012, Jens Mastrup has left the board of directors of BORREGAARD BIOPLANT ApS.
About BORREGAARD BIOPLANT ApS
BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The company was previously named REITZEL BIOPLANT ApS and PBH 26.815 ApS. The management consists of Martin Lemche. The board consists of Jean-Marc Maurice Denis Vandoorne-Feys (chair), Erik Desire V. Vanderhaegen, Marc Domien Josephina Mertens and Martin Lemche. The company is owned by Biobest Group NV. The company has 29 employees (2026). In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity in the 2025 report amounted to DKK 5,520,385.